An innovative medical device that uses neuromodulatory technology to address menstrual health symptoms and increase the productivity of women

一种创新的医疗设备，利用神经调节技术来解决月经健康症状并提高女性的生产力

• 批准号: 10039602
• 金额: $ 43.63万
• 依托单位: SAMPHIRE NEUROSCIENCE LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10039602
• 关键词: innovative; medical; device; uses; neuromodulatory

Samphire is a UK medical device SME with a core project team of Emile Radyte (CEO/project lead), Alexander Cook (COO/commercial lead) and Ervinas Bernatavicius (product manager/technical lead).A large majority of reproductive-age women experience menstruation-related symptoms and have missed work as a result, which has led to a loss of productivity through sickness, absence and underperformance by those women who go to work while feeling unwell. The annual cost of this productivity loss in the UK has been estimated at £17.4B. Current options for dealing with menstrual symptoms are limited, with a large emphasis on pharmacological solutions. This leaves women with few options to manage their symptoms.Samphire is developing a wearable, non-invasive medical device in the form of a hairband that uses personalised neuromodulatory technology to address mood and pain-related menstrual health symptoms. The device is being built alongside women and uniquely adapted for their needs.The SamphireNeuro Device will be a personalised, effective and innovative solution for pre-menstrual depression and menstrual pain experienced by four in five women. It will improve women's productivity, in some cases by over 23 days per year, positively impacting their wellbeing, work opportunities and equality.The device, which is being built on trusted and valid science, contains three key innovations that make it the first solution of its kind for an unaddressed need.

Samphire是一家英国医疗设备中小企业，其核心项目团队由Emile Radyte(首席执行官/项目主管)、Alexander Cook(首席运营官/商业主管)和Ervinas Bernatavicius(产品经理/技术主管)组成。大多数育龄妇女都会出现与月经有关的症状，并因此而错过工作，这导致那些因身体不适而上班的妇女因生病、缺勤和表现不佳而导致生产力下降。在英国，这种生产力损失每年造成的损失估计为17.4亿英磅。目前处理月经症状的选择有限，很大程度上强调药物解决方案。这使得女性几乎没有选择来管理她们的症状。Samphire正在开发一种可穿戴的、非侵入性的医疗设备，其形式是发带，它使用个性化的神经调节技术来解决与情绪和疼痛相关的月经健康症状。SamphireNeuro设备是与女性一起制造的，并针对她们的需求进行了独特的调整。SamphireNeuro设备将是一种个性化、有效和创新的解决方案，用于治疗五分之四的女性经历的经前抑郁和经痛。它将提高女性的生产力，在某些情况下每年超过23天，对她们的福祉、工作机会和平等产生积极影响。该设备建立在可信和有效的科学基础上，包含三项关键创新，使其成为首个解决未解决需求的同类解决方案。